Chapter 35 : Medico-Legal Issues in HIV/AIDS in the 21st Century

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Medico-Legal Issues in HIV/AIDS in the 21st Century, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap35-1.gif /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap35-2.gif


This chapter focuses on some of the key legal elements relating to human immunodeficiency virus (HIV) infection and AIDS. The AIDS Drug Assistance Program is one of the key government-funded programs that provide AIDS-related drugs to those who could otherwise not afford them. A recent study found that HIV therapies reduce infectivity by 60%. Access to HIV therapies reduces the viral load (or the amount of HIV present in a person’s bloodstream)—a key factor in curbing infectivity and in reducing the ability to transmit HIV. There is now evidence that AIDS, if untreated, affects the cognitive functioning of patients, sometimes quite early in the disease process. AIDS patients should be educated about the common neurological complications of HIV infection, including peripheral neuropathy as well as neurocognitive disorder. The American Medical Association has stated that physicians have an ethical obligation to provide care for patients with HIV infection and AIDS. AIDS has affected all aspects of family life. Injection drug use is responsible for over 30% of the transmission of HIV/AIDS in certain parts of this country, like New York City. It emphasized the need to protect human rights and human dignity in the context of the HIV/AIDS pandemic. Efforts to prevent the spread of HIV have helped decrease the transmission in developed countries. It is learned from experience that coercion in the form of threats, penalty, and discrimination is not an effective tool to prevent the spread of an epidemic such as AIDS.

Citation: Sahai-Srivastava S. 2009. Medico-Legal Issues in HIV/AIDS in the 21st Century, p 499-506. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch35
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Banta, W. F. 1993. AIDS in the Workplace: Legal Questions and Practical Answers, p. 30–71. Lexington Books, New York, NY.
2. Bartlett, J. G.,, and A. K. Finkbeiner. 1996. The Guide to Living with HIV Infection, p. 254280. Johns Hopkins University Press, Baltimore, MD.
3. Braithwaite, R. L.,, S. Stephens, and, K. Braithwaite. 1999. Risks associated with tattooing and body piercing. J. Public Health Policy 20:459470.
4. Burris, S.,, J. S. Vernick,, A. Ditzler, and, S. Strathdee. 2002. The legality of selling or giving syringes to injection drug users. J. Am. Pharm. Assoc. 42(6 Suppl. 2):S13S18.
5. Buss, W.,, W. Dornett,, L. Gasarch,, L. Hoyt,, K. Kelly,, D. Leifer,, A. Macher,, R. O’Brien,, M. Rhodes,, D. Robinson,, T. Schuck,, P. Stano, and, D. Webber. 1987. AIDS and the Law, p. 150. Wiley Law Publications, New York, NY.
6. Chhetri, D.,, P. Mukhopaddhaya, and, S. Gupta. 2002. AIDS and the medico-legal experts. J. Indian Med. Assoc. 100:698699.
7. Coffin, P. O.,, C. Fuller,, S. Blaney,, L. Vadnai,, S. Miller, and, D. Vlahov. 2004. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Clin. Infect. Dis. 38:438441.
8. Fee, E.,, and D. Fox. 1992. AIDS: The Making of a Chronic Disease, p. 50104. University of California Press, Berkeley.
9. Glantz, L. H. 1996. Legal Issues Regarding HIV Infection, p. 663674. In H. Libman and, R. A. Witzburg (ed.), HIV Infection. Little, Brown, and Company, Boston, MA.
10. Hamers, F. F.,, and A. M. Downs. 2004. The changing face of the HIV epidemic in Western Europe: what are the implications for public health policies ? Lancet 364:8394.
11. Harrington, J. A. 2002. The instrumental uses of autonomy: a review of AIDS law and policy in Europe. Soc. Sci. Med. 55:14251434.
12. Jarvis, R.,, M. Closen,, D. Hermann, and, A. Leonard. 1991. AIDS Law in a Nutshell. West Publishing Company, Saint Paul, MN.
13. Johnson, B.,, and C. Soskolne. 1986. AIDS: medico legal considerations for Canadian hospitals. Can. Med. Assoc. J. 135:10911096.
14. Loue, S. 1995. Legal and Ethical Aspects of HIV-Related Research, p. 145–148. Plenum Press, New York, NY.
15. Lyerly, A. D.,, and J. Anderson. 2001. Human immunodeficiency virus and assisted reproduction: reconsidering evidence, reframing ethics. Fertil. Steril. 75:843858.
16. Payne, M. A.,, and E. J. Lamb. 2004. Use of frozen semen to avoid human immunodeficiency virus type 1 transmission by donor insemination: a cost-effectiveness analysis. Fertil. Steril. 81:8091.
17. Porco, T. C.,, J. N. Martin,, K. A. Page-Shafer,, A. Cheng,, E. Charlebois,, R. M. Grant, and, D. H. Osmond. 2004. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18:8188.
18. Raffaele, D.,, T. Emmanuelle,, P. Olga,, B. Roberto,, N. Sergio, and, K. A. Stuart. 2001. Global review of legislation on HIV/AIDS: the issue of HIV testing. J. Acquir. Immune Defic. Syndr. 28:173179.
19. Sahai, S.,, and B. Jones. 2001. HIV-Associated Dementia. Online Medical Textbook. http://www.emedicine.com.
20. Schochetman, J.,, and J. R. George. 1994. AIDS Testing, 2nd ed., p. 2550. Springer-Verlag, New York, NY.
21. Scott, B. 1993. Testing, disclosure, and the right to privacy, p. 115149. In B. Scott,, H. Dalton,, J. Miller, and the Yale AIDS Law project (ed.), AIDS Law Today. Yale University Press, New Haven, CT.
22. Smith, W. S. 1998. Legal & Ethical Issues of HIV-Induced Dementia, p. 565568. In H. E. Gendelman,, S. A. Lipton,, L. Epstein, and, S. Swindells (ed.), The Neurology of AIDS. International Thomas Publishing, New York, NY.
23. Spielberg, F.,, R. O. Levine, and, M. Weaver. 2004. Self-testing for HIV: a new option for HIV prevention. Lancet Infect. Dis. 4:640646.
24. Taylor, M. M.,, H. Rotblatt,, J. T. Brooks,, J. Montoya,, G. Aynalem,, L. Smith,, K. Kenney,, L. Laubacher,, T. Bustamante,, R. Kim-Farley,, J. Fielding,, B. Bernard,, E. Daar, and, P. R. Kerndt. 2007. Epidemiologic investigation of a cluster of workplace HIV infections in the adult film industry: Los Angeles, California, 2004. Clin. Infect. Dis. 44:301305.
25. Terl, A. H. 1993. AIDS and the Law. A Basic Guide for the Nonlawyer, p. 1522. Hemisphere Publishing Corp., Washington, DC.
26. Webber, D. W. 1997. AIDS and the Law, 3rd ed., p. 97175. Wiley Law Publications, Somerset, NJ.
27. Weir, E. 2000. Rapid HIV testing. Can. Med. Assoc. J. 162:1605.
28. Wood, G.,, R. Marks, and, J. Dilley. 1990. AIDS Law for Mental Health Professionals. University of California at San Francisco AIDS Health Project, San Francisco.


Generic image for table

Do’s and don’ts of HIV law

Citation: Sahai-Srivastava S. 2009. Medico-Legal Issues in HIV/AIDS in the 21st Century, p 499-506. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch35
Generic image for table

Stand-alone disabling HIV conditions for adults

Citation: Sahai-Srivastava S. 2009. Medico-Legal Issues in HIV/AIDS in the 21st Century, p 499-506. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch35

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error